share_log

華領醫藥-B：股份發行人的證券變動月報表

HUA MEDICINE-B: Monthly Return of Equity Issuer on Movements in Securities

HKEX ·  Sep 4, 2024 04:45

Summary by Moomoo AI

華領醫藥-B（股份代號：02552.HK）於2024年9月4日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年8月31日的公司股本變動情況。報告顯示，華領醫藥的法定/註冊股本及已發行股份數量在8月份均無變動，普通股的法定/註冊股份數目維持在2,000,000,000股，面值為0.001 USD，而已發行股份（不包括庫存股份）數目保持在1,055,588,761股。此外，公司的股份期權計劃在本月內無新增發行，但有31,658股份期權失效，使得月底結存的股份期權數目微幅下降至52,799,265股。公司確認，所有證券發行或庫存股份的出售或轉讓均已獲得董事會授權，並遵守相關上市規則及法律規定。
華領醫藥-B（股份代號：02552.HK）於2024年9月4日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年8月31日的公司股本變動情況。報告顯示，華領醫藥的法定/註冊股本及已發行股份數量在8月份均無變動，普通股的法定/註冊股份數目維持在2,000,000,000股，面值為0.001 USD，而已發行股份（不包括庫存股份）數目保持在1,055,588,761股。此外，公司的股份期權計劃在本月內無新增發行，但有31,658股份期權失效，使得月底結存的股份期權數目微幅下降至52,799,265股。公司確認，所有證券發行或庫存股份的出售或轉讓均已獲得董事會授權，並遵守相關上市規則及法律規定。
Hua Ling Medicine-B (Stock code: 02552.HK) submitted the latest monthly report on securities changes to The Stock Exchange of Hong Kong Limited on September 4, 2024, reporting the company's capital changes as of August 31, 2024. The report shows that the statutory/registered share capital and the number of issued shares of Hua Ling Medicine remained unchanged in August, with the statutory/registered number of ordinary shares remaining at 2,000,000,000 shares, with a par value of 0.001 USD, while the number of issued shares (excluding treasury shares) remained at 1,055,588,761 shares. In addition, the company's stock options plan did not have any new issuances this month, but 31,658 stock options expired, resulting in a slight decrease in the number of outstanding stock options to 52,799,265 shares at the end of the month. The company confirms that all securities issuance or sale of treasury shares has been authorized by the board of directors and complies with relevant listing rules and legal requirements.
Hua Ling Medicine-B (Stock code: 02552.HK) submitted the latest monthly report on securities changes to The Stock Exchange of Hong Kong Limited on September 4, 2024, reporting the company's capital changes as of August 31, 2024. The report shows that the statutory/registered share capital and the number of issued shares of Hua Ling Medicine remained unchanged in August, with the statutory/registered number of ordinary shares remaining at 2,000,000,000 shares, with a par value of 0.001 USD, while the number of issued shares (excluding treasury shares) remained at 1,055,588,761 shares. In addition, the company's stock options plan did not have any new issuances this month, but 31,658 stock options expired, resulting in a slight decrease in the number of outstanding stock options to 52,799,265 shares at the end of the month. The company confirms that all securities issuance or sale of treasury shares has been authorized by the board of directors and complies with relevant listing rules and legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated